209 related articles for article (PubMed ID: 9535844)
1. Binding of bacterial peptidoglycan to CD14.
Dziarski R; Tapping RI; Tobias PS
J Biol Chem; 1998 Apr; 273(15):8680-90. PubMed ID: 9535844
[TBL] [Abstract][Full Text] [Related]
2. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS.
Jarvis BW; Lichenstein H; Qureshi N
Infect Immun; 1997 Aug; 65(8):3011-6. PubMed ID: 9234747
[TBL] [Abstract][Full Text] [Related]
3. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
Schwandner R; Dziarski R; Wesche H; Rothe M; Kirschning CJ
J Biol Chem; 1999 Jun; 274(25):17406-9. PubMed ID: 10364168
[TBL] [Abstract][Full Text] [Related]
4. Interactions of bacterial lipopolysaccharide and peptidoglycan with a 70 kDa and an 80 kDa protein on the cell surface of CD14+ and CD14- cells.
Triantafilou K; Triantafilou M; Dedrick RL
Hum Immunol; 2001 Jan; 62(1):50-63. PubMed ID: 11165715
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide.
Dziarski R; Viriyakosol S; Kirkland TN; Gupta D
Infect Immun; 2000 Sep; 68(9):5254-60. PubMed ID: 10948152
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu B; Hailman E; Wright SD
J Clin Invest; 1997 Jan; 99(2):315-24. PubMed ID: 9006000
[TBL] [Abstract][Full Text] [Related]
7. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.
Yu B; Wright SD
J Biol Chem; 1996 Feb; 271(8):4100-5. PubMed ID: 8626747
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.
Cunningham MD; Seachord C; Ratcliffe K; Bainbridge B; Aruffo A; Darveau RP
Infect Immun; 1996 Sep; 64(9):3601-8. PubMed ID: 8751905
[TBL] [Abstract][Full Text] [Related]
9. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein.
Tapping RI; Tobias PS
J Biol Chem; 1997 Sep; 272(37):23157-64. PubMed ID: 9287319
[TBL] [Abstract][Full Text] [Related]
10. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.
Triantafilou M; Triantafilou K; Fernandez N
Eur J Biochem; 2000 Apr; 267(8):2218-26. PubMed ID: 10759844
[TBL] [Abstract][Full Text] [Related]
11. Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.
Hermann C; Spreitzer I; Schröder NW; Morath S; Lehner MD; Fischer W; Schütt C; Schumann RR; Hartung T
Eur J Immunol; 2002 Feb; 32(2):541-51. PubMed ID: 11828371
[TBL] [Abstract][Full Text] [Related]
12. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages.
Gupta D; Jin YP; Dziarski R
J Immunol; 1995 Sep; 155(5):2620-30. PubMed ID: 7650392
[TBL] [Abstract][Full Text] [Related]
13. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses.
Kusunoki T; Hailman E; Juan TS; Lichenstein HS; Wright SD
J Exp Med; 1995 Dec; 182(6):1673-82. PubMed ID: 7500012
[TBL] [Abstract][Full Text] [Related]
14. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
[TBL] [Abstract][Full Text] [Related]
15. Human monocyte CD14 is upregulated by lipopolysaccharide.
Landmann R; Knopf HP; Link S; Sansano S; Schumann R; Zimmerli W
Infect Immun; 1996 May; 64(5):1762-9. PubMed ID: 8613389
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.
Tobias PS; Soldau K; Gegner JA; Mintz D; Ulevitch RJ
J Biol Chem; 1995 May; 270(18):10482-8. PubMed ID: 7537731
[TBL] [Abstract][Full Text] [Related]
17. Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes.
Dziarski R
J Biol Chem; 1991 Mar; 266(8):4719-25. PubMed ID: 2002021
[TBL] [Abstract][Full Text] [Related]
18. Interactions of CD14 with components of gram-positive bacteria.
Dziarski R; Ulmer AJ; Gupta D
Chem Immunol; 2000; 74():83-107. PubMed ID: 10608083
[No Abstract] [Full Text] [Related]
19. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan.
Wolfert MA; Murray TF; Boons GJ; Moore JN
J Biol Chem; 2002 Oct; 277(42):39179-86. PubMed ID: 12151399
[TBL] [Abstract][Full Text] [Related]
20. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.
Juan TS; Hailman E; Kelley MJ; Busse LA; Davy E; Empig CJ; Narhi LO; Wright SD; Lichenstein HS
J Biol Chem; 1995 Mar; 270(10):5219-24. PubMed ID: 7534291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
